Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Clinical Significance Of Microscopic Melanoma Metastases In The Nonhottest Sentinel Lymph Nodes.

Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes.

Su Luo1, Alice Z C Lobo2, Kenneth K Tanabe3

  • 1Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston.

JAMA Surgery
|April 2, 2015

Related Experiment Videos

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

22.1K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.5K
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

13.8K

View abstract on PubMed

Summary
This summary is machine-generated.

Removing non-hottest sentinel lymph nodes is crucial for accurate melanoma staging. Microscopic metastases in these nodes significantly correlate with disease progression and mortality, impacting patient survival rates.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Dermatology

Background:

  • A practice gap exists in sentinel lymph node (SLN) biopsy for melanoma, with variability in the number of SLNs removed.
  • Current protocols range from removing only the hottest SLN to removing all nodes with radioactivity above 10% of the hottest node.

Purpose of the Study:

  • To assess the clinical significance of melanoma metastases in non-hottest SLNs.
  • To determine the risk of disease progression based on SLN status and primary tumor characteristics.

Main Methods:

  • Retrospective review of 475 consecutive cutaneous melanoma patients undergoing SLN biopsy.
  • Analysis of 1575 SLNs, recording radioactivity counts, metastasis presence, and primary tumor characteristics.
  • Mean follow-up of 59 months, with data collection through 2012.

Related Experiment Videos

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

22.1K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.5K
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
06:09

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

13.8K

Main Results:

  • 19% of patients had positive SLNs; 21% of positive SLNs were missed if only the hottest node was removed.
  • Melanoma progression occurred in 43% of patients with any positive SLN, irrespective of hottest node status.
  • Primary tumor mitogenicity and positive SLN status were associated with increased mortality and decreased survival.

Conclusions:

  • Microscopic melanoma metastases in non-hottest SLNs are clinically significant and associated with disease progression and mortality.
  • Complete SLN removal is essential for accurate staging and risk stratification in melanoma patients.
  • Addressing this practice gap improves surgical management and patient outcomes.